Skip to main content

Table 1 Characteristics of scleroderma patients participating in the study at baseline

From: Can home rehabilitation impact impulse oscillometry and lung ultrasound findings in patients with scleroderma-associated interstitial lung disease? A pilot study

Variables  
Demographic/anthropometric data
 Age (years) 51 (40–63)
 BMI (kg/m2) 26.4 (24–31)
Clinical characteristics
 Limited cutaneous scleroderma (n, %) 7 (58.3)
 Diffuse cutaneous scleroderma (n, %) 5 (41.7)
 ILD (n, %) 12 (100%)
 PH (n, %) 3 (25%)
 Gastrointestinal symptoms (n, %) 6 (50%)
 Renal crisis (n, %) 1 (8.3%)
Serology
 Anti-TOPO I positivity (n, %) 8 (66.7%)
 Anti-RNAP III positivity (n, %) 3 (25%)
 Anti-centromere positivity (n, %) 1 (8.3%)
  1. Results expressed as the median (interquartile range) or number (%)
  2. ILD: interstitial lung disease (diagnoses by computed tomography); PH: pulmonary hypertension; anti-TOPO I: antibodies against topoisomerase I; anti-RNAP III: antibodies against RNA polymerase III